We are live on ! Find out more
PRHC

P.R. Herzig & Co Portfolio holdings

AUM $45.9M
1-Year Est. Return 15.88%
This Fund
S&P 500
This Quarter Est. Return
+0%
1 Year Est. Return
+15.88%
3 Year Est. Return
+49.95%
5 Year Est. Return
+89.91%
10 Year Est. Return
–
AUM
$49.4M
AUM Growth
-$9.01M
Cap. Flow
-$8.7M
Cap. Flow %
-17.61%
Top 10 Hldgs %
43.1%
Holding
57
New
4
Increased
9
Reduced
25
Closed
11

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.25M
2
URI icon
United Rentals
URI
+$1.21M
3
ASTE icon
Astec Industries
ASTE
+$1.07M
4
NVO
Novo Nordisk
NVO
+$349K
5
PTC icon
PTC
PTC
+$127K

Top Sells

Rank Stock Value
1
POT
Potash Corp Of Saskatchewan
POT
+$2.09M
2
GM icon
General Motors
GM
+$1.51M
3
QCOM icon
Qualcomm
QCOM
+$1.15M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$876K
5
MSFT icon
Microsoft
MSFT
+$830K

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Consumer Discretionary 17.88%
3 Industrials 13.26%
4 Healthcare 11.19%
5 Miscellaneous 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCL
26
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$830K 1.68%
20,450
-2,900
-12% -$122K
NEM icon
27
Newmont
NEM
$139B
$783K 1.58%
33,500
-11,700
-26% -$292K
UNH icon
28
UnitedHealth
UNH
$355B
$732K 1.48%
6,000
-700
-10% -$82.8K
SYK icon
29
Stryker
SYK
$124B
$698K 1.41%
7,300
– –
V icon
30
Visa
V
$709B
$685K 1.39%
10,200
– –
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.13T
$679K 1.37%
25,540
-4,061
-14% -$109K
SLB icon
32
SLB Ltd
SLB
$81.6B
$664K 1.34%
7,700
+1,300
+20% +$117K
BMY icon
33
Bristol-Myers Squibb
BMY
$137B
$641K 1.3%
9,637
-2,799
-23% -$184K
CEF icon
34
Sprott Physical Gold and Silver Trust
CEF
$8.31B
$597K 1.21%
51,200
-24,400
-32% -$292K
FNF icon
35
Fidelity National Financial
FNF
$12.7B
$593K 1.2%
23,090
-8,354
-27% -$216K
ORCL icon
36
Oracle
ORCL
$438B
$576K 1.17%
14,300
– –
NKE icon
37
Nike
NKE
$57B
$518K 1.05%
9,600
– –
BKNG icon
38
Booking.com
BKNG
$152B
$512K 1.04%
11,125
– –
FSLR icon
39
First Solar
FSLR
$22.6B
$409K 0.83%
8,700
+1,800
+26% +$101K
SBUX icon
40
Starbucks
SBUX
$122B
$375K 0.76%
7,000
– –
CLD
41
DELISTED
Cloud Peak Energy Inc
CLD
$366K 0.74%
78,600
-40,500
-34% -$234K
JNJ icon
42
Johnson & Johnson
JNJ
$640B
$361K 0.73%
3,700
-382
-9% -$38.3K
NVO
43
Novo Nordisk
NVO
$205B
$340K 0.69%
+12,400
New +$349K
SPY icon
44
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$298K 0.6%
1,450
+15
+1% +$3.15K
EMAN
45
DELISTED
eMagin Corporation
EMAN
$53K 0.11%
20,000
-6,000
-23% -$15.6K
HGT
46
DELISTED
Hugoton Royalty Trust
HGT
$40K 0.08%
11,370
– –
ABBV icon
47
AbbVie
ABBV
$456B
– –
-4,600
Closed -$269K
FOLD
48
DELISTED
Amicus Therapeutics
FOLD
– –
-47,000
Closed -$511K
NQP
49
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
– –
-10,904
Closed -$152K
PFE icon
50
Pfizer
PFE
$160B
– –
-9,486
Closed -$313K
1
2
3

Similar funds

NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
AVA
Accel VIII Associates Palo Alto, California $65.1M AUM
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return

P.R. Herzig & Co's Q2 2015 Portfolio in Review

As of Q2 2015, P.R. Herzig & Co held 57 positions worth $49.4M, down 15% from $58.4M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

P.R. Herzig & Co withdrew a net $8.7M in Q2 2015, closing 11 positions and reducing 25 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, P.R. Herzig & Co opened a new position in GSK worth $1.16M.

  • P.R. Herzig & Co's largest Q2 2015 buy was GSK: 22,200 shares worth $1.16M.
  • P.R. Herzig & Co added most to PTC in Q2 2015, an estimated $127K increase.
  • P.R. Herzig & Co's biggest Q2 2015 reduction was General Motors, cutting an estimated $1.51M.
  • P.R. Herzig & Co fully exited Potash Corp Of Saskatchewan in Q2 2015, selling an estimated $2.09M.
  • P.R. Herzig & Co's ten largest holdings make up 43% of its $49.4M portfolio in Q2 2015.
  • P.R. Herzig & Co opened 4 new positions and closed 11 in Q2 2015.
  • P.R. Herzig & Co's portfolio value fell 15% quarter-over-quarter to $49.4M.

Based on P.R. Herzig & Co's 13F filing for Q2 2015, filed 10 Jul 2015.